Suppr超能文献

细胞周期蛋白A和Ki-67表达作为接受手术和术后放疗的喉癌患者局部区域复发及预后的预测指标

Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy.

作者信息

Saarilahti Kauko, Kajanti Mikael, Kouri Mauri, Aaltonen Leena-Maija, Franssila Kaarle, Joensuu Heikki

机构信息

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):986-95. doi: 10.1016/s0360-3016(03)00736-3.

Abstract

PURPOSE

To investigate the association between the cancer cell proliferation fraction and the risk of recurrence in laryngeal cancer patients treated without systemic therapy.

METHODS AND MATERIALS

Paraffin-embedded tumor samples from 90 laryngeal cancer patients were stained for cyclin A and the Ki-67 antigen by immunohistochemistry. The patients were treated with partial or total laryngectomy followed by postoperative radiotherapy to a total dose of 50 Gy or greater. The median follow-up time was 91 months (minimum 48 months).

RESULTS

High cyclin A expression (>19% positive cancer cell nuclei, the highest tertile) was associated with a high rate of locoregional tumor recurrence and unfavorable disease-free and overall survival as compared with cases with a lower expression (p = 0.025, 0.032, and 0.042, respectively). In a multivariate analysis, high cyclin A expression was an independent predictor of poor disease-free survival (RR 2.4, 95% CI 1.2-4.9, p = 0.013) and overall survival (RR 2.1, 1.2-3.6, p = 0.012), together with a poor Karnofsky's performance status and the presence of positive margins at surgery. Ki-67 expression was not an independent predictor of survival, but cancers with high Ki-67 expression (>34% nuclei positive, the highest tertile) recurred more frequently locoregionally when treated with split-course radiotherapy than when treated with a continuous course of therapy (p = 0.035), whereas the presence of a planned split did not influence the frequency of locoregional recurrences when Ki-67 expression was lower (p = 0.93).

CONCLUSION

Cancer cell cyclin A expression is a novel predictive factor for outcome in laryngeal cancer treated with surgery and postoperative radiotherapy. Planned gaps in the radiotherapy course are deleterious in patients with a high proliferative fraction, and immunostaining for the Ki-67 antigen may be useful in identification of such patients.

摘要

目的

探讨在未接受全身治疗的喉癌患者中,癌细胞增殖分数与复发风险之间的关联。

方法与材料

对90例喉癌患者的石蜡包埋肿瘤样本进行免疫组织化学染色,检测细胞周期蛋白A(cyclin A)和Ki-67抗原。患者接受部分或全喉切除术,术后放疗总剂量为50 Gy或更高。中位随访时间为91个月(最短48个月)。

结果

与细胞周期蛋白A低表达的病例相比,高细胞周期蛋白A表达(>19%阳性癌细胞核,最高三分位数)与局部区域肿瘤复发率高、无病生存期和总生存期不良相关(p分别为0.025、0.032和0.042)。在多变量分析中,高细胞周期蛋白A表达是无病生存期差(风险比2.4,95%可信区间1.2 - 4.9,p = 0.013)和总生存期差(风险比2.1,1.2 - 3.6,p = 0.012)的独立预测因素,同时还与卡诺夫斯基表现状态差和手术切缘阳性有关。Ki-67表达不是生存的独立预测因素,但高Ki-67表达(>34%细胞核阳性,最高三分位数)的癌症在接受分段放疗时比接受连续放疗时局部区域复发更频繁(p = 0.035),而当Ki-67表达较低时,计划分段的存在并不影响局部区域复发的频率(p = 0.93)。

结论

癌细胞周期蛋白A表达是手术和术后放疗治疗喉癌预后的一个新的预测因素。放疗疗程中的计划间隙对增殖分数高的患者有害,对Ki-67抗原进行免疫染色可能有助于识别此类患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验